COCP Cocrystal Pharma, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

- Industry (SIC)
- PHARMACEUTICAL PREPARATIONS (2834) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 10
- List Date
- 2008-04-01
- CIK
- 0001412486
- Next Earnings
- 2026-11-13
- EPS Forecast
- ($0.17) (3 est.)
- Headquarters
- Bothell, WA
- Homepage
- https://www.cocrystalpharma.com
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI). The company has one reportable and operating segment dedicated to the research and development company's novel orally administered antiviral influe…
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 21.99% | -20.70% | 34.93% | -9.55% | -14.22% | -1.27% | 1.86% |
| Feb | -12.29% | -4.46% | -32.53% | -12.27% | -7.49% | 7.14% | -10.32% |
| Mar | -12.03% | -1.31% | 3.65% | -5.41% | -20.67% | -3.81% | -6.60% |
| Apr | -17.48% | -11.32% | 27.18% | 3.33% | 6.34% | 40.20% | 8.04% |
| May | -8.87% | -15.37% | -10.74% | 47.06% | 8.23% | -18.84% | 0.25% |
| Jun | 7.76% | -0.70% | 7.17% | 0.43% | -9.70% | -5.41% | -0.07% |
| Jul | -7.20% | 1.65% | 7.69% | -20.42% | 16.11% | -22.64% | -4.14% |
| Aug | 1.74% | -0.55% | 16.73% | -7.22% | -18.92% | 23.40% | 2.53% |
| Sep | -8.70% | -22.40% | -32.73% | 2.39% | -16.67% | 2.68% | -12.57% |
| Oct | -12.53% | -31.02% | -9.04% | 3.51% | -13.49% | -14.75%* | -12.89% |
| Nov | -5.02% | 11.38% | 13.10% | 19.39% | -2.75% | -- | 7.22% |
| Dec | -22.62% | -31.34% | -7.41% | -1.22% | -4.95% | -- | -13.51% |
| Total | -57.73% | -76.94% | -7.53% | 5.71% | -58.96% | -8.49% | -33.99% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary
Overall assessment: BEARISH (Confidence level: 6/10)
Key drivers:
- Bearish technical signals from MACD and RSI
- High volatility, indicating increased risk
- Recent news headlines have been generally positive, but no significant catalysts have emerged to support the stock price
Primary risks:
- Continued bearish momentum could lead to further declines
- Volatility remains high, increasing the likelihood of sudden price swings
Investment thesis: COCP's recent performance has been lackluster, driven by negative technical signals and high volatility. While news headlines have been positive, they have not had a significant impact on the stock price.
Recent news sentiment impact: Neutral, with no clear correlation between recent news and the stock's movement.
Technical Analysis
Trend Direction: Bearish short-term (1-4 weeks), Medium-term (1-3 months)
Support/Resistance Levels: Key levels to monitor include SMA 20 ($1.05) and Bollinger Bands' middle band ($1.05).
Momentum Signals:
- RSI interpretation: Neutral, with an RSI value of 34.53 indicating no clear overbought or oversold conditions.
- MACD signal: Bearish, with a histogram value of -0.07 indicating a bearish momentum signal.
- Bollinger Bands position: Squeeze, with the price touching the middle band.
Volume Analysis: Volume trends and institutional interest signals are mixed, with no clear indications of increased buying or selling pressure.
News & Sentiment Analysis
Recent Headlines Summary: Positive news headlines have focused on COCP's business updates and product developments.
Sentiment Assessment: Positive sentiment prevails, with 4 out of 5 recent headlines having a positive tone.
Catalyst Identification: No significant catalysts have emerged in the recent news headlines.
Market Narrative: The news headlines have not had a significant impact on the stock price, which has remained bearish. The market narrative suggests that the lack of catalysts and negative technical signals are driving the price decline.
Risk & Volatility Assessment
Beta Interpretation: High risk relative to the market (beta > 1.5).
Volatility Regime: Current volatility is high (HV20 48.3%, HV30 52.3%), indicating increased risk.
Options Market Signals: No options data available.
Downside Protection: Support levels and risk management considerations are key, with SMA 20 ($1.05) serving as a potential stop-loss level.
Market Context & Positioning
Sector Performance: COCP's sector is neutral, with no clear trends emerging.
Institutional Activity: No significant institutional activity has been observed in the recent volume trends.
Correlation Analysis: The stock's movement is not strongly correlated with the market (R-squared = 0.26).
Relative Valuation: COCP is trading near the lower end of its range, indicating potential value.
Key Levels & Action Items
Critical Price Levels: SMA 20 ($1.05) and Bollinger Bands' middle band ($1.05) are key levels to monitor.
Breakout/Breakdown Levels: A breakout above $1.14 or a breakdown below $0.92 could trigger significant price movements.
Time-Sensitive Catalysts: No immediate catalysts have emerged, but upcoming earnings announcements could provide potential catalysts.
Risk Management: Stop-loss levels and position sizing considerations are key, with SMA 20 ($1.05) serving as a potential stop-loss level.
By analyzing the data, we can conclude that COCP's recent performance has been bearish, driven by negative technical signals and high volatility. While news headlines have been positive, they have not had a significant impact on the stock price. The market narrative suggests that the lack of catalysts and negative technical signals are driving the price decline.
COCP Options Activity & IV Rank
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
High volatility - stock moves more than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Renaissance Technologies Hedge fund Jim Simons | $189K | #2891 of 3138 | +44.9% | 13F | |
| Citadel Hedge fund Ken Griffin | $47K | #6006 of 6285 | new | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
COCP Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
COCP Insider Trading (Form 4)
Latest: 2026-08-06| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Phillip Md Et Al Frost | Director | Buy (P) | +10,000 | $0.98 | $9.8K | EDGAR |
| 2026-08-06 | Phillip Md Et Al Frost | Director | Buy (P) | +10,000 | $0.98 | $9.8K | EDGAR |
| 2026-08-05 | Phillip Md Et Al Frost | Director | Buy (P) | +75,000 | $0.94 | $70.6K | EDGAR |
| 2026-06-03 | James Sapirstein | Chief Executive Officer | Grant (A) | +235,000 opt | — | EDGAR | |
| 2026-02-25 | Phillip Md Et Al Frost | Director | Buy (P) | +20,000 | $1.00 | $20.0K | EDGAR |
| 2026-02-09 | Phillip Md Et Al Frost | Director | Buy (P) | +50,000 | $0.95 | $47.3K | EDGAR |
| 2026-01-13 | Fred Hassan | Director | Grant (A) | +16,410 opt | — | EDGAR | |
| 2026-01-13 | Anthony J Japour | Director | Grant (A) | +16,410 opt | — | EDGAR | |
| 2026-01-13 | Steven D Rubin | Director | Grant (A) | +16,410 opt | — | EDGAR | |
| 2026-01-13 | Richard C Pfenniger Jr | Director | Grant (A) | +16,410 opt | — | EDGAR | |
| 2026-01-13 | Sam Lee | President and Co-CEO | Grant (A) | +49,229 opt | — | EDGAR | |
| 2026-01-13 | James Joseph Martin | Co-CEO and CFO | Grant (A) | +49,229 opt | — | EDGAR | |
| 2026-01-13 | Roger D. Kornberg | Director | Grant (A) | +24,615 opt | — | EDGAR | |
| 2026-01-13 | Phillip Md Et Al Frost | Director | Grant (A) | +24,615 opt | — | EDGAR | |
| 2026-01-02 | Phillip Md Et Al Frost | Director | Buy (P) | +50,000 | $0.95 | $47.3K | EDGAR |
COCP Insider Holdings
8 insiders · @ $0.97| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Steven D Rubin | Director | 2,660,242 | $2.59M | $0 | 7 | 2026-01-13 |
| 2 | Phillip Md Et Al Frost | Director | 2,020,651 | $1.96M | $310.0K | 18 | 2026-08-06 |
| 3 | Fred Hassan | Director | 1,383,009 | $1.34M | $0 | 4 | 2026-01-13 |
| 4 | Sam Lee | President and Co-CEO | 76,355 | $74.2K | $0 | 7 | 2026-01-13 |
| 5 | Roger D. Kornberg | Director | 67,878 | $66.0K | $0 | 6 | 2026-01-13 |
| 6 | James Joseph Martin | Co-CEO and CFO | 44,167 | $42.9K | $0 | 8 | 2026-01-13 |
| 7 | Richard C Pfenniger Jr | Director | 31,400 | $30.5K | $41.1K | 7 | 2026-01-13 |
| 8 | Anthony J Japour | Director | 14,924 | $14.5K | $0 | 6 | 2026-01-13 |
COCP Board & Officers
As of SEC filings through Aug 21, 2026Directors 6
- Phillip Md Et Al Frost · since Mar 17, 2014
- Roger D. Kornberg · since Mar 17, 2014
- Steven D Rubin · since Mar 17, 2014
- Richard C Pfenniger Jr · since May 27, 2021
- Fred Hassan · since Apr 20, 2023
- Carol L Brosgart · since Aug 12, 2026
Officers 2
- James Joseph Martin · Co-CEO and CFO · listed since Jul 2023
- James Sapirstein · Chief Executive Officer · since Jun 3, 2026
10% owners 1
- Phillip Md Et Al Frost · listed since Apr 2023
Changes in the last 10 years (15)
| Aug 12, 2026 | Carol L Brosgart became a director |
| Jun 3, 2026 | James Sapirstein became Chief Executive Officer |
| Mar 10, 2026 | The company announced the departure of Anthony J Japour from the board in an SEC filing |
| Jul 20, 2023 | Sam Lee listed as President and Co-CEO (previously President and Co-Interim CEO) in SEC filings |
| Jul 20, 2023 | James Joseph Martin listed as Co-CEO and CFO (previously Chief Financial Officer) in SEC filings |
| Apr 20, 2023 | Fred Hassan became a director |
| Apr 6, 2023 | Phillip Md Et Al Frost first listed as a 10% owner in an SEC filing |
| Jul 20, 2021 | Sam Lee listed as President and Co-Interim CEO (previously President) in SEC filings |
| May 27, 2021 | Richard C Pfenniger Jr became a director |
| Jun 24, 2020 | Phillip Md Et Al Frost no longer listed as a 10% owner in SEC filings |
| Oct 29, 2019 | Raymond F Schinazi no longer listed as a director in SEC filings |
| Apr 4, 2019 | Anthony J Japour became a director |
| Feb 1, 2019 | Todd R. Brady became a director |
| Sep 24, 2018 | James Joseph Martin listed as Chief Financial Officer (previously Interim CFO) in SEC filings |
| Feb 23, 2017 | James Joseph Martin became Interim CFO |
Not reported recently (7)
- Sam Lee · Last reported as President and Co-CEO in an SEC filing dated Jan 13, 2026
- Frost Gamma Investments Trust · Last reported as a 10% owner in an SEC filing dated Apr 6, 2023
- Raymond F Schinazi · Last reported as a 10% owner in an SEC filing dated May 6, 2021
- Gary Wilcox · Last reported as Interim CEO in an SEC filing dated Jun 24, 2020
- Todd R. Brady · Last reported as a director in an SEC filing dated Feb 11, 2019
- Jane Ph D Hsiao · Last reported as a director in an SEC filing dated Sep 24, 2018
- David S Block · Last reported as a director in an SEC filing dated Sep 24, 2018
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.